HealthDay (3/20, Mundell , Miller) reports that approximately “1 in every 10 U.S. children ages 5 to 17 has been diagnosed with attention deficit hyperactivity disorder (ADHD), according to” data from the National Center for Health Statistics. These “data from the National Health Interview Survey covers the years 2020 through 2022 and came from in-person or phone interviews involving a representative sample of American homes.”

The survey “found that 11.3% of school-age children have been diagnosed with ADHD, with boys more likely to have this diagnosis (14.5%) than girls (8%).” These findings were published as an NCHS Data Brief.

Related Links:

— “One in 10 U.S. School-Age Kids Have ADHD: Report,” Ernie Mundell, Carole Tanzer Miller, HealthDay, March , 2024

Bloomberg Law (3/20, Pazanowski , Subscription Publication) reports, “A Trump administration rule that eliminated the Affordable Care Act’s protections for LGBTQ+ people must be vacated, Boston-based advocacy groups told a federal court in a long-running case.” The Biden Administration “has been promising to undo former President Donald Trump’s 2020 ‘rollback rule’ since early 2021 and still hasn’t done so, the advocacy groups said.”

And though HHS “keeps saying a new version is imminent, the potential for another change of administration means people can’t wait any longer, the groups said in Tuesday’s brief to the US District Court for the District of Massachusetts.”

Related Links:

— Bloomberg Law (requires login and subscription)

Psychiatric News (3/20) reports, “Body dysmorphic disorder (BDD), defined as excessive preoccupation with perceived flaws in personal appearance, affects almost two in every 100 teens, according to” a study. Additionally, the research “found that BDD is much more common in girls than boys.”

The researchers also found that “children and adolescents with BDD are highly likely to have other psychiatric disorders—especially depression and anxiety—and to experience psychosocial problems, self-harm and/or suicide attempts.”

The findings were published in the Journal of the American Academy of Child and Adolescent Psychiatry.

Related Links:

— “Body Dysmorphic Disorder or Appearance Preoccupation Common in Teens,” Psychiatric News, March 20, 2024

Healio (3/20, Herpen) reports, “While psychedelic use may be associated with fewer psychotic symptoms among adolescents, the link between psychedelics and manic symptoms appears to be associated with genetic vulnerability to schizophrenia or bipolar disorder, data show.”

Investigators came to this conclusion after analyzing “data from 16,255 adolescent twins (54.7% girls) born between July 1992 and December 2005, who first participated in the Child and Adolescent Twin Study in Sweden at age 9 years and were later assessed at ages 15, 18 and 24 years.” The findings were published in JAMA Psychiatry.

Related Links:

— “Link between psychedelic use, manic symptoms in teens may be associated with genetics,” Robert Herpen, MA, Healio, March 20, 2024

MedPage Today (3/20, DePeau-Wilson ) reports, “Five distinct suicide profiles that could improve detection and treatment of co-existing health conditions and bolster suicide prevention strategies were identified in a cross-sectional study.” In the “analysis of 306,800 suicide deaths, individuals who faced physical health challenges comprised the largest profile class of the five (31.7%).”

The data indicated that “decedents with this profile (class 4) also had the lowest rates of disclosing suicidal intent (14.4%) or leaving a suicide note (25.1%).” Although “physical health conditions made up the largest profile, the remaining profiles were comprised of individuals who predominantly faced mental health or substance abuse conditions: Class 1: comorbid mental health and substance use problems (13.5%); Class 2: mental health problems (17.6%); Class 3: crisis, alcohol-related, and intimate-partner problems (18%);” and “Class 5: polysubstance problems (19.2%).”

The findings were published in JAMA Psychiatry.

Related Links:

— MedPage Today (requires login and subscription)